Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Perrigo Company    PRGO   US7142901039

PERRIGO COMPANY (PRGO)

6
 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Company
Perrigo Co. plc is a global healthcare supplier.It develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, and active pharmaceutical ingredients.The company was formed as a part of merger between Perrigo Co. and Elan Corp. Plc as on December... 
Sector
Pharmaceuticals
Calendar
05/05Earnings Release
More about the company
Surperformance© ratings of Perrigo Company
Trading Rating : Investor Rating :
More Ratings
Financials ($)
Sales 2015 4 348 M
EBIT 2015 1 267 M
Net income 2015 837 M
Debt 2015 1 200 M
Yield 2015 0,35%
Sales 2016 4 723 M
EBIT 2016 1 444 M
Net income 2016 973 M
Debt 2016 1 860 M
Yield 2016 0,36%
PER 2015 25,58
PER 2016 20,59
EV / Sales 2015 5,46x
EV / Sales 2016 5,16x
Capitalization 22 524 M
More Financials
Latest news on PERRIGO COMPANY
02/25 PERRIGO COMPANY PLC : ex-dividend day
02/05 PERRIGO : Reports Record Second Quarter Revenue, Adjusted Net Income And Adjuste..
02/04 PERRIGO : Announces Quarterly Dividend
02/04 EXCLUSIVE - CINVEN TESTS APPETITE FO : sources
01/29 PERRIGO : Galmed and Perrigo in manufacturing services agreement for aramchol AP..
01/28 PERRIGO : Galmed and Perrigo Execute Manufacturing Agreement for Large-Scale Ara..
01/21 PERRIGO : enters gummy vitamin market
01/13 PERRIGO : inks deal with Ferrara to enter gummy vitamins and dietary supplement ..
More news
Sector news Pharmaceuticals - NEC
10:52a NOVARTIS : FDA approves first lower-cost biotech drug
10:24a AKORN : Bills on electric chair moves to Alabama House
10:01a SANOFI : Appoints Robert Castaigne as Audit Committee Chairman
Plus d'actualités du secteur Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF